Suppr超能文献

部署下一代测序和 CRISPR-Cas 系统以支持疟疾控制和消除的诊断和监测的潜在机遇和挑战:在非洲。

Potential Opportunities and Challenges of Deploying Next Generation Sequencing and CRISPR-Cas Systems to Support Diagnostics and Surveillance Towards Malaria Control and Elimination in Africa.

机构信息

National Institute for Medical Research, Dar es Salaam, Tanzania.

School of Life Sciences and Bio-Engineering, Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.

出版信息

Front Cell Infect Microbiol. 2022 Jul 13;12:757844. doi: 10.3389/fcimb.2022.757844. eCollection 2022.

Abstract

Recent developments in molecular biology and genomics have revolutionized biology and medicine mainly in the developed world. The application of next generation sequencing (NGS) and CRISPR-Cas tools is now poised to support endemic countries in the detection, monitoring and control of endemic diseases and future epidemics, as well as with emerging and re-emerging pathogens. Most low and middle income countries (LMICs) with the highest burden of infectious diseases still largely lack the capacity to generate and perform bioinformatic analysis of genomic data. These countries have also not deployed tools based on CRISPR-Cas technologies. For LMICs including Tanzania, it is critical to focus not only on the process of generation and analysis of data generated using such tools, but also on the utilization of the findings for policy and decision making. Here we discuss the promise and challenges of NGS and CRISPR-Cas in the context of malaria as Africa moves towards malaria elimination. These innovative tools are urgently needed to strengthen the current diagnostic and surveillance systems. We discuss ongoing efforts to deploy these tools for malaria detection and molecular surveillance highlighting potential opportunities presented by these innovative technologies as well as challenges in adopting them. Their deployment will also offer an opportunity to broadly build in-country capacity in pathogen genomics and bioinformatics, and to effectively engage with multiple stakeholders as well as policy makers, overcoming current workforce and infrastructure challenges. Overall, these ongoing initiatives will build the malaria molecular surveillance capacity of African researchers and their institutions, and allow them to generate genomics data and perform bioinformatics analysis in-country in order to provide critical information that will be used for real-time policy and decision-making to support malaria elimination on the continent.

摘要

分子生物学和基因组学的最新发展主要在发达国家彻底改变了生物学和医学。下一代测序(NGS)和 CRISPR-Cas 工具的应用现在有望支持流行地区国家检测、监测和控制地方性疾病和未来的流行疾病,以及新出现和再次出现的病原体。大多数传染病负担最高的低收入和中等收入国家(LMIC)仍然在很大程度上缺乏生成和执行基因组数据分析的能力。这些国家也没有部署基于 CRISPR-Cas 技术的工具。对于包括坦桑尼亚在内的 LMIC 国家来说,不仅要关注使用这些工具生成和分析数据的过程,而且要关注利用这些发现制定政策和决策,这一点至关重要。在这里,我们讨论了 NGS 和 CRISPR-Cas 在非洲消除疟疾的背景下的前景和挑战。这些创新工具急需加强现有的诊断和监测系统。我们讨论了正在努力部署这些工具用于疟疾检测和分子监测,突出了这些创新技术带来的潜在机会,以及采用这些技术所面临的挑战。它们的部署还将为在病原体基因组学和生物信息学方面广泛建立国内能力提供机会,并使他们能够在国内生成基因组数据并进行生物信息学分析,以提供将用于实时政策和决策的关键信息,从而支持非洲大陆消除疟疾。总体而言,这些正在进行的举措将建立非洲研究人员及其机构的疟疾分子监测能力,使他们能够在国内生成基因组数据并进行生物信息学分析,以提供将用于实时政策和决策的关键信息,从而支持非洲大陆消除疟疾。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/223b/9326448/345c4a6a9536/fcimb-12-757844-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验